
March 2, 2010 (Chinavestor) Chinese medical equipment developer, manufacturer and marketer Mindray Medical (NYSE:MR) reported 2009 full year and fourth quarter financial result after the close yesterday. The company reported solid revenue and earnings growth and issued a conservative revenue guidance. Yet the company actually fell in the after-market trading.
It looks to me that some investors don't get the big picture. The issue is always to find companies that demonstrate solid revenue and earnings growth. Not just portray a potential but actually deliver. And Mindray Medical (NYSE:MR) is one of them. We looked up financial reports going back to 2004 and draw a revenue and earnings graph - see below. What else do I have to say?
Feb. 13, 2010 (Chinavestor) Investing 101 says earnings and revenue growth are driving stock prices for the long haul. Let's take a look at 3SBio Inc. (NASDAQ:SSRX) keeping this simple yet often ov...
(Sept. 2, 2009 - Zou Soueidan) It's about that time of year again. After a lull in the immediate public concern over a swine flu outbreak, the media has once again made us aware that a potential epide...
(Sept. 2, 2009) It appears that investors are beginning to take notice of Lotus Pharmaceuticals (OTC:LTUS). The GeoTeam has been tracking LTUS with some trepidation, due in part to the following is...
(Aug. 31, 2009 - Chinavestor) Sinovac (AMEX:SVA), this small cap Chinese vaccine maker, jumped $3.39 or a staggering 53.64% today. Underlying volume was unusually high, over twenty times more than in ...


